GLP-1 Case Study Name: Richard J., a 58-year-old male Medical History: Type 2 Diabetes Mellitus (diagnosed 7 years ago) Obesity (BMI 35 kg/m) Hypertension (well-controlled on an ACE inhibitor) Mild diabetic retinopathy Current Medications: Metformin 1000 mg twice daily, glimepiride 2 mg once daily, and lisinopril 20 mg once daily Clinical Presentation Richard presents a routine follow-up
Ngoi ra, n cn cha cc thnh phn c li khc nhau nh Axit Hyaluronic 30% gip dng m cho ln da mt mi c hiu qu m lu di
The treatment begins with a consultation to determine your goals and healthcare requirements
Industry analysts predict that outsourcing of GLP-1 peptide production will accelerate, mirroring trends in other biologics segments ( [14] )
Why We Picked Them: Sabrina leads the clinical team
The prospect of prebiotics such as oligofructose (FOS), galacto-oligosaccharide (GOS), inulin, and phenolic acids applied to support bone quality has been elucidated in several studies (29)